Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults with Schizophrenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 6-Week Inpatient Study

Authors

Leslie Citrome, New York Medical CollegeFollow
David Walling
Courtney Zeni
Marina Komaroff
Alexandra Park

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

5-2019

DOI

10.1016/j.biopsych.2019.03.315

Journal Title

Biological Psychiatry

Department

Psychiatry and Behavioral Sciences

Recommended Citation

Citrome, L., Walling, D., Zeni, C., Komaroff, M., & Park, A. (2019). Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults with Schizophrenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 6-Week Inpatient Study. Biological Psychiatry, 85 (10), S126. https://doi.org/10.1016/j.biopsych.2019.03.315